Analytical Data
-
基因名
MMP15
- Application
-
别名
MMP15;Matrix metalloProteinase-15
-
种属
Human
-
表达系统
E. coli
-
标签
His tag N-Terminus
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
P51511
-
表达区间
1-669aa
-
氨基酸序列
MGSDPSAPGRPGWTGSLLGDREEAARPRLLPLLLVLLGCLGLGVAAEDAEVHAENWLRLYGYLPQPSRHMSTMRSAQILASALAEMQRFYGIPVTGVLDEETKEWMKRPRCGVPDQFGVRVKANLRRRRKRYALTGRKWNNHHLTFSIQNYTEKLGWYHSMEAVRRAFRVWEQATPLVFQEVPYEDIRLRRQKEADIMVLFASGFHGDSSPFDGTGGFLAHAYFPGPGLGGDTHFDADEPWTFSSTDLHGNNLFLVAVHELGHALGLEHSSNPNAIMAPFYQWKDVDNFKLPEDDLRGIQQLYGTPDGQPQPTQPLPTVTPRRPGRPDHRPPRPPQPPPPGGKPERPPKPGPPVQPRATERPDQYGPNICDGDFDTVAMLRGEMFVFKGRWFWRVRHNRVLDNYPMPIGHFWRGLPGDISAAYERQDGRFVFFKGDRYWLFREANLEPGYPQPLTSYGLGIPYDRIDTAIWWEPTGHTFFFQEDRYWRFNEETQRGDPGYPKPISVWQGIPASPKGAFLSNDAAYTYFYKGTKYWKFDNERLRMEPGYPKSILRDFMGCQEHVEPGPRWPDVARPPFNPHGGAEPGADSAEGDVGDGDGDFGAGVNKDGGSRVVVQMEEVARTVNVVMVLVPLLLLLCVLGLTYALVQMQRKGAPRVLLYCKRSLQEWV
-
分子量
75.8 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
Matrix metalloproteinase 15 (MMP15) is a member of the matrix metalloproteinase family, which plays a crucial role in the degradation of extracellular matrix components. This property is significant in various physiological and pathological processes, including tissue remodeling, wound healing, and cancer metastasis. MMP15 specifically has been implicated in biological processes such as angiogenesis and cellular migration, making it a potential target for therapeutic interventions in cancer and other diseases characterized by excessive matrix degradation. Recent studies have highlighted its upregulation in various tumor types, correlating with poor prognosis and aggressive disease phenotypes. Consequently, the development of recombinant MMP15 proteins allows for the exploration of its structural and functional properties, providing insights into its role in disease progression. Such recombinant proteins serve as valuable tools for characterizing MMP15’s enzymatic activity, identifying substrate specificity, and evaluating potential inhibitors. Understanding the mechanisms of MMP15 can contribute to the design of novel therapeutic strategies, ultimately aiming to regulate its activity to combat diseases associated with aberrant extracellular matrix remodeling. This research area is particularly relevant in the context of cancer therapeutics, where modulating the tumor microenvironment may enhance treatment efficacy and improve patient outcomes.












